XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT

Realtime	Geld	Brief	Zeit
	0,142	0,193	27.04.
	0,000	0,000	26.04.

Realtime

Geld

Brief

Zeit

0,142

0,193

27.04.

0,000

26.04.

XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 02.10.2023

The following instruments on Boerse Frankfurt do have their last trading day on 02.10.2023
Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 02.10.2023

ISIN Name
US0843101017 PHENOMEX INC. DL-,00005
CA87320M1014 TAAT GLOBAL ALTERNATIVES
GB00BJMD6M39 DWF GROUP PLC LS-,01
NL0000303709 AEGON NV (DEMAT.) EO-12
US2787001096 EBET INC. O.N.
US4500472042 IRSA INV. Y REPR. ADR 10
US87166B1026 SYNEOS HEALTH A DL-,01
US88337K3023 THE9 LTD.ADR/30 DL-,01

Großer Insider-Report 2024 von Dr. Dennis Riedl

Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.

Hier klicken

Zeit	Aktuelle Nachrichten
10.04.	Aegon prices $760M senior unsecured notes
10.04.	Aegon Ltd.: Aegon prices USD 760 million of senior unsecured notes	The Hague, April 10, 2024 - Aegon has successfully priced USD 760 million of senior unsecured notes with a fixed coupon of 5.5% and a tenor of three years. Net proceeds from this issuance will be used... ► Artikel lesen
09.04.	Aegon (AEG) Unveils New Share Buyback Worth EUR 35 Million
09.04.	Aegon to repurchase shares for share-based compensation plans
09.04.	Aegon Ltd.: Aegon to repurchase shares for share-based compensation plans	The Hague, April 9, 2024 - Aegon today announces it will repurchase common shares for an amount of EUR 35 million to meet its obligations resulting from the share-based compensation plans for senior... ► Artikel lesen

Zeit

Aktuelle Nachrichten

10.04.

Aegon prices $760M senior unsecured notes

10.04.

Aegon Ltd.: Aegon prices USD 760 million of senior unsecured notes

The Hague, April 10, 2024 - Aegon has successfully priced USD 760 million of senior unsecured notes with a fixed coupon of 5.5% and a tenor of three years. Net proceeds from this issuance will be used...
► Artikel lesen

09.04.

Aegon (AEG) Unveils New Share Buyback Worth EUR 35 Million

09.04.

Aegon to repurchase shares for share-based compensation plans

09.04.

Aegon Ltd.: Aegon to repurchase shares for share-based compensation plans

The Hague, April 9, 2024 - Aegon today announces it will repurchase common shares for an amount of EUR 35 million to meet its obligations resulting from the share-based compensation plans for senior...
► Artikel lesen

Zeit	Aktuelle Nachrichten
02.10.23	XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 02.10.2023		The following instruments on Boerse Frankfurt do have their last trading day on 02.10.2023Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 02.10.2023ISIN NameUS0843101017 PHENOMEX... ► Artikel lesen

Zeit

Aktuelle Nachrichten

02.10.23

XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 02.10.2023

Zeit	Aktuelle Nachrichten
18.04.	EBET, Inc. - 8-K, Current Report
13.02.	EBET, Inc. - 10-Q, Quarterly Report
29.01.	EBET, Inc. - 10-K/A, Annual Report
12.01.	EBET, Inc. - 10-K, Annual Report
30.12.23	EBET, Inc. - NT 10-K, Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405

Zeit

Aktuelle Nachrichten

18.04.

EBET, Inc. - 8-K, Current Report

13.02.

EBET, Inc. - 10-Q, Quarterly Report

29.01.

EBET, Inc. - 10-K/A, Annual Report

12.01.

EBET, Inc. - 10-K, Annual Report

30.12.23

EBET, Inc. - NT 10-K, Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405

Zeit	Aktuelle Nachrichten
18.04.	IRSA INVESTMENTS & REPRESENTATIONS INC - 6-K, Report of foreign issuer
11.04.	IRSA INVESTMENTS & REPRESENTATIONS INC - 6-K, Report of foreign issuer
03.04.	IRSA INVESTMENTS & REPRESENTATIONS INC - 6-K, Report of foreign issuer
25.03.	Altisource Portfolio, Irsa Inversiones Y Representaciones, La Rosa in real estate movers
21.03.	IRSA INVESTMENTS & REPRESENTATIONS INC - 6-K, Report of foreign issuer

Zeit

Aktuelle Nachrichten

18.04.

IRSA INVESTMENTS & REPRESENTATIONS INC - 6-K, Report of foreign issuer

11.04.

IRSA INVESTMENTS & REPRESENTATIONS INC - 6-K, Report of foreign issuer

03.04.

IRSA INVESTMENTS & REPRESENTATIONS INC - 6-K, Report of foreign issuer

25.03.

Altisource Portfolio, Irsa Inversiones Y Representaciones, La Rosa in real estate movers

21.03.

IRSA INVESTMENTS & REPRESENTATIONS INC - 6-K, Report of foreign issuer

Zeit	Aktuelle Nachrichten
22.03.	Research and Markets: 2024 Biopharmaceutical Sponsor Interaction with Clinical Site Networks Pulse Report Featuring IQVIA, ICON, Parexel, Fortrea (formerly Labcorp), PPD/Thermo Fisher, and Syneos Health - ResearchAndMarkets.com	The "2024 Biopharmaceutical Sponsor Interaction with Clinical Site Networks Pulse Report" has been added to ResearchAndMarkets.com's offering. The biopharmaceutical clinical development landscape... ► Artikel lesen
08.02.	Research Solutions, Inc.: Research Solutions Reports Fiscal Second Quarter 2024 Results	Reports 18.3% Revenue Increase and ARR of $15.6 Million HENDERSON, Nev., Feb. 8, 2024 /PRNewswire/ -- Research Solutions, Inc. (NASDAQ: RSSS), a trusted partner providing cloud-based workflow... ► Artikel lesen
04.01.	Crossject engages Syneos Health for U.S. commercial launch of ZEPIZURE	Press Release Crossject engages Syneos Health for U.S. commercial launch of ZEPIZURE® Crossject expanding market access activities in preparation for filing for marketing authorization ZEPIZURE®... ► Artikel lesen
27.11.23	Research Solutions, Inc.: Research Solutions Announces Acquisition of scite	Transforms Search and Discovery Solutions for Researchers by Delivering Breakthrough AI Technology Adds $3.6 Million in Annualized Software Subscription Revenue HENDERSON, Nev.... ► Artikel lesen
16.11.23	Odyssey Health Selects Syneos to Support Concussion Treatment Trial

Zeit

Aktuelle Nachrichten

22.03.

Research and Markets: 2024 Biopharmaceutical Sponsor Interaction with Clinical Site Networks Pulse Report Featuring IQVIA, ICON, Parexel, Fortrea (formerly Labcorp), PPD/Thermo Fisher, and Syneos Health - ResearchAndMarkets.com

The "2024 Biopharmaceutical Sponsor Interaction with Clinical Site Networks Pulse Report" has been added to ResearchAndMarkets.com's offering. The biopharmaceutical clinical development landscape...
► Artikel lesen

08.02.

Research Solutions, Inc.: Research Solutions Reports Fiscal Second Quarter 2024 Results

Reports 18.3% Revenue Increase and ARR of $15.6 Million HENDERSON, Nev., Feb. 8, 2024 /PRNewswire/ -- Research Solutions, Inc. (NASDAQ: RSSS), a trusted partner providing cloud-based workflow...
► Artikel lesen

04.01.

Crossject engages Syneos Health for U.S. commercial launch of ZEPIZURE

Press Release Crossject engages Syneos Health for U.S. commercial launch of ZEPIZURE® Crossject expanding market access activities in preparation for filing for marketing authorization ZEPIZURE®...
► Artikel lesen

27.11.23

Research Solutions, Inc.: Research Solutions Announces Acquisition of scite

Transforms Search and Discovery Solutions for Researchers by Delivering Breakthrough AI Technology Adds $3.6 Million in Annualized Software Subscription Revenue HENDERSON, Nev....
► Artikel lesen

16.11.23

Odyssey Health Selects Syneos to Support Concussion Treatment Trial

Zeit	Aktuelle Nachrichten
Fr	TAAT Global Alternatives Inc (2): TAAT Global settles $80,415 debt with shares
Fr	TAAT Global Alternatives Inc.: TAAT Provides Update on Status of MCTO and Closes Debt Settlement
19.04.	TAAT Global Alternatives Inc.: TAAT Announces Shares for Debt Settlement
19.04.	TAAT Global Alternatives Inc (2): TAAT Global to issue 303,456 shares for debt of $80,415
12.04.	TAAT Global Alternatives Inc (2): TAAT to issue update on FY 2023 results filing April 26

Zeit

Aktuelle Nachrichten

TAAT Global Alternatives Inc (2): TAAT Global settles $80,415 debt with shares

TAAT Global Alternatives Inc.: TAAT Provides Update on Status of MCTO and Closes Debt Settlement

19.04.

TAAT Global Alternatives Inc.: TAAT Announces Shares for Debt Settlement

19.04.

TAAT Global Alternatives Inc (2): TAAT Global to issue 303,456 shares for debt of $80,415

12.04.

TAAT Global Alternatives Inc (2): TAAT to issue update on FY 2023 results filing April 26

Zeit	Aktuelle Nachrichten
Di	The9 LTD - 6-K, Report of foreign issuer
16.04.	The9 Limited Achieved 66% Increase in Net Revenues and Turned Net Loss into Net Income for the Year Ended December 31, 2023	SHANGHAI, April 15, 2024 /PRNewswire/ -- The9 Limited (NASDAQ: NCTY) ("The9"), an established Internet company, today announced it filed its annual report on Form 20-F for the year ended December... ► Artikel lesen
15.04.	The9 LTD - 20-F, Annual and transition report of foreign private issuers
15.04.	The9 Limited: A New Generation of Antidepressant Drug Precision Treatment Based on Revolutionary AI Technology is Born	SHANGHAI, April 15, 2024 /PRNewswire/ -- The9 Limited (Nasdaq: NCTY) ("The9"), an established Internet company, today announced that its investee WM Therapeutics Co., Ltd. ("WM Therapeutics") has... ► Artikel lesen
26.03.	The9 LTD - 6-K, Report of foreign issuer

Zeit

Aktuelle Nachrichten

The9 LTD - 6-K, Report of foreign issuer

16.04.

The9 Limited Achieved 66% Increase in Net Revenues and Turned Net Loss into Net Income for the Year Ended December 31, 2023

SHANGHAI, April 15, 2024 /PRNewswire/ -- The9 Limited (NASDAQ: NCTY) ("The9"), an established Internet company, today announced it filed its annual report on Form 20-F for the year ended December...
► Artikel lesen

15.04.

The9 LTD - 20-F, Annual and transition report of foreign private issuers

15.04.

The9 Limited: A New Generation of Antidepressant Drug Precision Treatment Based on Revolutionary AI Technology is Born

SHANGHAI, April 15, 2024 /PRNewswire/ -- The9 Limited (Nasdaq: NCTY) ("The9"), an established Internet company, today announced that its investee WM Therapeutics Co., Ltd. ("WM Therapeutics") has...
► Artikel lesen

26.03.

The9 LTD - 6-K, Report of foreign issuer

Unternehmen / Aktien	Kurs	%
AEGON LTD	5,850	+0,38 %
DWF GROUP PLC	1,060	0,00 %
EBET INC	0,744	0,00 %
IRSA INVERSIONES Y REPRESENTACIONES SA ADR	8,550	-0,58 %
SYNEOS HEALTH INC	40,000	0,00 %
TAAT GLOBAL ALTERNATIVES INC	0,170	+1,49 %
THE9 LTD ADR	6,150	0,00 %

Unternehmen / Aktien

Kurs

AEGON LTD

5,850

+0,38 %

DWF GROUP PLC

1,060

0,00 %

EBET INC

0,744

0,00 %

IRSA INVERSIONES Y REPRESENTACIONES SA ADR